Gender differences in hereditary hemorrhagic telangiectasia severity von Mora-Luján, J M, Iriarte, A, Alba, E, Sánchez-Corral, M A, Cerdà, P, Cruellas, F, Ordi, Q, Corbella, X, Ribas, J, Castellote, J, Riera-Mestre, A

Volltext

Adrenomedullin as a potential biomarker involved in patients with hereditary hemorrhagic telangiectasia von Iriarte, A., Ochoa-Callejero, L., García-Sanmartín, J., Cerdà, P., Garrido, P., Narro-Íñiguez, J., Mora-Luján, JM, Jucglà, A., Sánchez-Corral, MA, Cruellas, F., Gamundi, E., Ribas, J., Castellote, J., Viñals, F., Martínez, A., Riera-Mestre, A.

Volltext

Current HHT genetic overview in Spain and its phenotypic correlation: data from RiHHTa registry von Sánchez-Martínez, Rosario, Iriarte, Adriana, Mora-Luján, José María, Patier, José Luis, López-Wolf, Daniel, Ojeda, Ana, Torralba, Miguel Angel, Juyol, María Coloma, Gil, Ricardo, Aéón, Sol, Salazar-Mendiguchía, Joel, Riera-Mestre, Antoni, Alonso-Cotoner, C, Aéón, S, Beneyto, M, Bermejo-Olano, M. M, Cerdà, P, Cruellas, F, De Los Santos, A, Díez, L, Fernández, A, García-Morillo, J. S, Gil, R, Gómez-Cerezo, J. F, Gómez del Olmo, V, González-García, A, Iriarte, A, Iglesias, P, Juyol, M. C, López-Osle, N, López, M, López-Wolf, D, Mora-Luján, J. M, Moreno, M, Ojeda, A, Patier, J. L, Pérez de León, J. A, Perez, M. L, Riera-Mestre, A, Rivera, S, Rodríguez, S, Sánchez-Martínez, R, Torralba, M. A, Zarrabeitia, R

Volltext

Adrenomedullin as a potential biomarker involved in patients with hereditary hemorrhagic telangiectasia von Iriarte, Adriana, Ochoa-Callejero, L, García-Sanmartín, J, Cerdà, P, Garrido, P, Narro-Íñiguez, J, Mora Luján, José María, Jucglà, Anna, Sánchez-Corral, M.A, Cruellas, F, Gamundi, E, Ribas, J, Castellote Alonso, José, Viñals Canals, Francesc, Martínez, A, Riera Mestre, Antoni

Volltext

Microsomal epoxide hydrolase and glutathione S-transferase polymorphisms in relation to laryngeal carcinoma risk von To-Figueras, Jordi, Gené, Manuel, Gómez-Catalán, Jesús, Piqué, Esther, Borrego, Natividad, Caballero, Manuel, Cruellas, Francesc, Raya, Anna, Dicenta, Manuel, Corbella, Jacint

Volltext

Gender differences in hereditary hemorrhagic telangiectasia severity von Mora-Luján, José María, Iriarte, Adriana, Alba, E, Sánchez-Corral, M. A, Cerdà, Pau, Cruellas, F, Ordi, Q, Corbella Virós, Xavier, Ribas, Jesús, Castellote, J, Riera-Mestre, Antoni

Volltext bestellen

Failure analysis of magnets in a servomotor by Mössbauer and X-ray diffraction von Rubín, J., Bartolomé, J., Cruellas, F., Flotats, I., Belmonte, I.

Volltext

Advanced reactor concepts for oxidative coupling of methane von Cruellas, A., Melchiori, T., Gallucci, F., van Sint Annaland, M.

Volltext

Techno-economic analysis of oxidative coupling of methane: Current state of the art and future perspectives von Cruellas, A., Bakker, J.J., van Sint Annaland, M., Medrano, J.A., Gallucci, F.

Volltext

473P Predictive factors for drug-induced liver injury in patients with ER-positive HER2-negative metastatic breast cancer treated with first-line cyclin-dependent kinase 4/6 inhibi... von Cano, K.S. Vega, Javierre, G. Villacampa, Baselga, P. Mascaró, Mirallas, O., Adelantado, E. Zamora, Gomez, L. Sanz, Ortiz, C., Lapena, M. Cruellas, Arumi de Dios, M., Puy, M. Borrell, Filippi-Arriaga, F., Joval, L., Yaringaño, J.G., Martínez-Albaladejo, P., Buch, P.B., Esteban, P., Ruiz-Ortega, L., Manich, C. Saura, Riveiro-Barciela, M., Ezquerra, M. Bellet

Volltext

Comparison of entropy difference in the cooling process von Cruellas, G Rios

Volltext

27P Impact of chemotherapy (CT) use and stromal tumor-infiltrating lymphocytes (sTILs) in stage I triple-negative breast cancer (TNBC) von Barberi, V., Panet, F., Joval, L., Jaramillo, J.F. Chabla, Adelantado, E. Zamora, Pimentel, I., Puy, M. Borrell, Ezquerra, M. Bellet, Arumi de Dios, M.A., Gomez, L. Sanz, Calzado, E. Monescillo, Ortiz, C., Rezqallah Aron, M.A., Escrivá-De-Romaní, S., Lapena, M. Cruellas, Jimenez, J., Espinosa-Bravo, M., Cámara, V. Peg, Manich, C. Saura, Oliveira, M.

Volltext

250P Liver Toxicity (LT) in patients (pts) with ER-positive HER2-negative metastatic breast cancer (MBC) treated with first-line Cyclin-Dependent Kinase 4/6 inhibitors (CDKi) von Cano, K.S. Vega, Mascaro, P., Mirallas, O., Filippi-Arriaga, F., Joval, L., Zamora, E., Gomez, L. Sanz, Velez, C. Ortiz, Lapena, M. Cruellas, Arumi de Dios, M.A., Puy, M. Borrell, Esteban, P., Ruiz-Ortega, L., Buch, P.B., Yaringaño, J., Lores, G. Molina, Gomez-Puerto, D., Manich, C. Saura, Riveiro-Barciela, M., Bellet-Ezquerra, M.

Volltext